Literature DB >> 31298741

Treatment of allergic disease with nanoemulsion adjuvant vaccines.

Jessica J O'Konek1, James R Baker1.   

Abstract

Entities:  

Year:  2019        PMID： 31298741      PMCID： PMC6952560          DOI： 10.1111/all.13977

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  8 in total

1.  Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens.

Authors:  L R Stanberry; J K Simon; C Johnson; P L Robinson; J Morry; M R Flack; S Gracon; A Myc; T Hamouda; J R Baker
Journal:  Vaccine       Date:  2011-11-08       Impact factor: 3.641

2.  Nanoemulsion adjuvant-driven redirection of TH2 immunity inhibits allergic reactions in murine models of peanut allergy.

Authors:  Jessica J O'Konek; Jeffrey J Landers; Katarzyna W Janczak; Rishi R Goel; Anna M Mondrusov; Pamela T Wong; James R Baker
Journal:  J Allergy Clin Immunol       Date:  2018-04-11       Impact factor: 10.793

3.  Distinct pathways of humoral and cellular immunity induced with the mucosal administration of a nanoemulsion adjuvant.

Authors:  Anna U Bielinska; Paul E Makidon; Katarzyna W Janczak; Luz P Blanco; Benjamin Swanson; Douglas M Smith; Tiffany Pham; Zsuzsanna Szabo; Jolanta F Kukowska-Latallo; James R Baker
Journal:  J Immunol       Date:  2014-02-14       Impact factor: 5.422

4.  Association between specific timothy grass antigens and changes in TH1- and TH2-cell responses following specific immunotherapy.

Authors:  Véronique Schulten; Victoria Tripple; John Sidney; Jason Greenbaum; April Frazier; Rafeul Alam; David Broide; Bjoern Peters; Alessandro Sette
Journal:  J Allergy Clin Immunol       Date:  2014-07-16       Impact factor: 10.793

5.  Intranasal immunization of ferrets with commercial trivalent influenza vaccines formulated in a nanoemulsion-based adjuvant.

Authors:  Tarek Hamouda; Joyce A Sutcliffe; Susan Ciotti; James R Baker
Journal:  Clin Vaccine Immunol       Date:  2011-05-04

6.  Lack of allergy to timothy grass pollen is not a passive phenomenon but associated with the allergen-specific modulation of immune reactivity.

Authors:  D Hinz; G Seumois; A M Gholami; J A Greenbaum; J Lane; B White; D H Broide; V Schulten; J Sidney; P Bakhru; C Oseroff; E Wambre; E A James; W W Kwok; B Peters; P Vijayanand; A Sette
Journal:  Clin Exp Allergy       Date:  2016-05       Impact factor: 5.018

7.  Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine.

Authors:  Paul E Makidon; Anna U Bielinska; Shraddha S Nigavekar; Katarzyna W Janczak; Jessica Knowlton; Alison J Scott; Nicholas Mank; Zhengyi Cao; Sivaprakash Rathinavelu; Michael R Beer; J Erby Wilkinson; Luz P Blanco; Jeffrey J Landers; James R Baker
Journal:  PLoS One       Date:  2008-08-13       Impact factor: 3.240

8.  Formulation, high throughput in vitro screening and in vivo functional characterization of nanoemulsion-based intranasal vaccine adjuvants.

Authors:  Pamela T Wong; Pascale R Leroueil; Douglas M Smith; Susan Ciotti; Anna U Bielinska; Katarzyna W Janczak; Catherine H Mullen; Jeffrey V Groom; Erin M Taylor; Crystal Passmore; Paul E Makidon; Jessica J O'Konek; Andrzej Myc; Tarek Hamouda; James R Baker
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240
  8 in total
  1 in total

1.  Mucosal Nanoemulsion Allergy Vaccine Suppresses Alarmin Expression and Induces Bystander Suppression of Reactivity to Multiple Food Allergens.

Authors:  Mohammad Farazuddin; Jeffrey J Landers; Katarzyna W Janczak; Hayley K Lindsey; Fred D Finkelman; James R Baker; Jessica J O'Konek
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.